Acta Neurologica Scandinavica 2012-10-01

Vigabatrin-associated retinal damage: potential biochemical mechanisms.

M K Heim, B E Gidal

Index: Acta Neurol. Scand 126(4) , 219-28, (2012)

Full Text: HTML

Abstract

Vigabatrin (VGB), an irreversible inhibitor of gamma-aminobutyric acid (GABA) transaminase, is approved as adjunct treatment of refractory partial seizures as well as infantile spasms. Although VGB has been proven to be effective, its use is limited by the risk of retinopathy and associated peripheral visual field defects. This review describes and analyzes current literature related to potential pathophysiologic mechanisms underlying VGB-mediated cellular toxicity. Animal data suggest that GABA mediates neural excitotoxicity. The amino acid taurine is concentrated in retinal cells, and deficiency of this amino acid may be involved in VGB-mediated retinal degeneration and possible phototoxicity.© 2012 John Wiley & Sons A/S.

Related Compounds

  • Vigabatrin
  • Vigabatrin

Related Articles:

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

2010-01-01

[Chem. Res. Toxicol. 23 , 171-83, (2010)]

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

Chemical genetics reveals a complex functional ground state of neural stem cells.

2007-05-01

[Nat. Chem. Biol. 3(5) , 268-273, (2007)]

Neural computational prediction of oral drug absorption based on CODES 2D descriptors.

2010-03-01

[Eur. J. Med. Chem. 45 , 930-40, (2010)]

Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.

2010-12-15

[Bioorg. Med. Chem. Lett. 20 , 7312-6, (2010)]

More Articles...